These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2136764)

  • 1. Treatment of metastatic malignant melanoma with trimetrexate: a phase II study.
    Odujinrin O; Goldberg D; Doroshow J; Leong L; Margolin K; Grove W; Carr B; Akman S
    Med Pediatr Oncol; 1990; 18(1):49-52. PubMed ID: 2136764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study.
    Iscoe NA; Eisenhauer EA; Bodurtha AJ
    Invest New Drugs; 1990 Feb; 8(1):121-3. PubMed ID: 2140563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma.
    Licht JD; Gonin R; Antman KH
    Cancer Chemother Pharmacol; 1991; 28(3):223-5. PubMed ID: 1830249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections.
    Jolivet J; Landry L; Pinard MF; McCormack JJ; Tong WP; Eisenhauer E
    Cancer Chemother Pharmacol; 1987; 20(2):169-72. PubMed ID: 2959389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric phase I trial and pharmacokinetic study of trimetrexate.
    Balis FM; Patel R; Luks E; Doherty KM; Holcenberg JS; Tan C; Reaman GH; Belasco J; Ettinger LJ; Zimm S
    Cancer Res; 1987 Sep; 47(18):4973-6. PubMed ID: 2957048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical response to trimetrexate as sole therapy for nonsmall cell lung cancer.
    Maroun J
    Semin Oncol; 1988 Apr; 15(2 Suppl 2):17-21. PubMed ID: 2835816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimetrexate and cyclophosphamide for metastatic inoperable nonsmall cell lung cancer.
    Mattson K; Maasilta P; Tammilehto L; Holsti LR; Grove W
    Semin Oncol; 1988 Apr; 15(2 Suppl 2):32-7. PubMed ID: 2835817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of trimetrexate therapy for metastatic colorectal carcinoma.
    Ajani JA; Abbruzzese JL; Faintuch JS; Patt YZ; Boman BM; Jackson DE; Levin B; Krakoff IH
    Cancer Invest; 1990; 8(6):619-21. PubMed ID: 2149834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I studies of trimetrexate using single and weekly dose schedules.
    Huan SD; Legha SS; Raber MN; Krakoff IH
    Invest New Drugs; 1991 May; 9(2):199-206. PubMed ID: 1831442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of trimetrexate in recurrent anaplastic glioma. National Cancer Institute of Canada Clinical Trials Group Study.
    Cairncross JG; Eisenhauer EA; Macdonald DR; Rathbone MP; Moore MJ; Sawka CA; MacCormick RE; Kerr IG
    Can J Neurol Sci; 1990 Feb; 17(1):21-3. PubMed ID: 2138053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 schedule.
    Stewart JA; McCormack JJ; Tong W; Low JB; Roberts JD; Blow A; Whitfield LR; Haugh LD; Grove WR; Lopez AJ
    Cancer Res; 1988 Sep; 48(17):5029-35. PubMed ID: 2970294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.
    Grochow LB; Noe DA; Dole GB; Rowinsky EK; Ettinger DS; Graham ML; McGuire WP; Donehower RC
    J Natl Cancer Inst; 1989 Jan; 81(2):124-30. PubMed ID: 2909752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimetrexate: a phase 2 study in previously treated patients with metastatic breast cancer.
    Leiby JM
    Semin Oncol; 1988 Apr; 15(2 Suppl 2):27-31. PubMed ID: 2966983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.
    Kris MG; D'Acquisto RW; Gralla RJ; Burke MT; Marks LD; Fanucchi MP; Heelan RT
    Am J Clin Oncol; 1989 Feb; 12(1):24-6. PubMed ID: 2536213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.
    Grochow LB; Noe DA; Ettinger DS; Donehower RC
    Cancer Chemother Pharmacol; 1989; 24(5):314-20. PubMed ID: 2758561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
    Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity reactions to trimetrexate.
    Grem JL; King SA; Costanza ME; Brown TD
    Invest New Drugs; 1990 May; 8(2):211-4. PubMed ID: 2143501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties.
    Lin JT; Bertino JR
    Cancer Invest; 1991; 9(2):159-72. PubMed ID: 1830825
    [No Abstract]   [Full Text] [Related]  

  • 19. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
    Allegra CJ; Chabner BA; Tuazon CU; Ogata-Arakaki D; Baird B; Drake JC; Simmons JT; Lack EE; Shelhamer JH; Balis F
    N Engl J Med; 1987 Oct; 317(16):978-85. PubMed ID: 2958710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumonia.
    Kovacs JA; Allegra CJ; Kennedy S; Swan JC; Drake J; Parrillo JE; Chabner B; Masur H
    Am J Trop Med Hyg; 1988 Nov; 39(5):491-6. PubMed ID: 2973755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.